美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA090705"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
76282-323-05 76282-323 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20100426 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 400 mg/1 500 CAPSULE in 1 BOTTLE (76282-323-05)
76282-323-27 76282-323 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20130320 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 400 mg/1 270 CAPSULE in 1 BOTTLE (76282-323-27)
76282-323-90 76282-323 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20130320 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 400 mg/1 90 CAPSULE in 1 BOTTLE (76282-323-90)
76282-321-27 76282-321 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20130320 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 100 mg/1 270 CAPSULE in 1 BOTTLE (76282-321-27)
76282-321-01 76282-321 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20100426 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 100 mg/1 100 CAPSULE in 1 BOTTLE (76282-321-01)
76282-321-05 76282-321 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20100426 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 100 mg/1 500 CAPSULE in 1 BOTTLE (76282-321-05)
76282-627-01 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 100 CAPSULE in 1 BOTTLE (76282-627-01)
76282-627-30 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (76282-627-30)
76282-627-60 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 60 CAPSULE in 1 BOTTLE (76282-627-60)
76282-627-90 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 90 CAPSULE in 1 BOTTLE (76282-627-90)
76282-627-05 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 500 CAPSULE in 1 BOTTLE (76282-627-05)
76282-627-18 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 180 CAPSULE in 1 BOTTLE (76282-627-18)
76282-627-27 76282-627 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20180913 N/A ANDA ANDA090705 Exelan Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 270 CAPSULE in 1 BOTTLE (76282-627-27)
70518-4261-0 70518-4261 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20250122 N/A ANDA ANDA090705 REMEDYREPACK INC. GABAPENTIN 100 mg/1 30 CAPSULE in 1 BLISTER PACK (70518-4261-0)
76420-020-90 76420-020 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20200610 N/A ANDA ANDA090705 Asclemed USA, Inc. GABAPENTIN 300 mg/1 90 CAPSULE in 1 BOTTLE (76420-020-90)
76420-020-24 76420-020 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20200610 N/A ANDA ANDA090705 Asclemed USA, Inc. GABAPENTIN 300 mg/1 240 CAPSULE in 1 BOTTLE (76420-020-24)
76420-020-30 76420-020 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20200610 N/A ANDA ANDA090705 Asclemed USA, Inc. GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (76420-020-30)
76420-020-60 76420-020 HUMAN PRESCRIPTION DRUG GABAPENTIN GABAPENTIN CAPSULE ORAL 20200610 N/A ANDA ANDA090705 Asclemed USA, Inc. GABAPENTIN 300 mg/1 60 CAPSULE in 1 BOTTLE (76420-020-60)
63187-031-30 63187-031 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20190101 N/A ANDA ANDA090705 Proficient Rx LP GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (63187-031-30)
63187-031-00 63187-031 HUMAN PRESCRIPTION DRUG Gabapentin Gabapentin CAPSULE ORAL 20190101 N/A ANDA ANDA090705 Proficient Rx LP GABAPENTIN 300 mg/1 100 CAPSULE in 1 BOTTLE (63187-031-00)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase